STOCK TITAN

Paragon 28 to Present at the 36th Annual Piper Sandler Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Paragon 28 (NYSE: FNA), a specialized medical device company focusing on foot and ankle orthopedics, has announced its participation in the 36th Annual Piper Sandler Healthcare Conference. Chairman and CEO Albert DaCosta and CFO Chadi Chahine will engage in a fireside chat on Tuesday, December 3, 2024, at 8:30 a.m. Eastern Time. The presentation will be accessible via live webcast and archived recording on the company's investor relations website at ir.paragon28.com.

Paragon 28 (NYSE: FNA), una società di dispositivi medici specializzata in ortopedia della caviglia e del piede, ha annunciato la sua partecipazione alla 36ª Conferenza Annuale Healthcare di Piper Sandler. Il presidente e CEO Albert DaCosta e il CFO Chadi Chahine parteciperanno a una chiacchierata informale martedì 3 dicembre 2024, alle 8:30 ora orientale. La presentazione sarà accessibile tramite webcast dal vivo e registrazione archiviata sul sito web delle relazioni con gli investitori dell'azienda all'indirizzo ir.paragon28.com.

Paragon 28 (NYSE: FNA), una empresa especializada en dispositivos médicos centrados en ortopedia del pie y tobillo, ha anunciado su participación en la 36ª Conferencia Anual de Salud de Piper Sandler. El presidente y CEO Albert DaCosta y el CFO Chadi Chahine participarán en una charla informal el martes 3 de diciembre de 2024, a las 8:30 a.m. hora del Este. La presentación será accesible a través de una transmisión en vivo y grabación archivada en el sitio web de relaciones con inversores de la empresa en ir.paragon28.com.

Paragon 28 (NYSE: FNA)는 발과 발목 정형외과에 집중하는 전문 의료기기 회사로, 제36회 연례 파이퍼 샌들러 헬스케어 컨퍼런스에 참여한다고 발표했습니다. 회장 겸 CEO인 알버트 다코스타(Albert DaCosta)와 CFO인 차디 샤힌(Chadi Chahine)은 2024년 12월 3일 화요일 동부 표준시 기준 오전 8시 30분에 화상 대화에 참여할 예정입니다. 발표는 회사의 투자자 관계 웹사이트인 ir.paragon28.com에서 생중계 및 기록된 방송을 통해 접근할 수 있습니다.

Paragon 28 (NYSE: FNA), une société spécialisée dans les dispositifs médicaux axée sur l'orthopédie du pied et de la cheville, a annoncé sa participation à la 36ème Conférence Annuelle Piper Sandler Healthcare. Le président et PDG Albert DaCosta et le CFO Chadi Chahine participeront à une discussion informelle le mardi 3 décembre 2024, à 8h30, heure de l'Est. La présentation sera accessible via un webinaire en direct et un enregistrement archivé sur le site des relations avec les investisseurs de l'entreprise à l'adresse ir.paragon28.com.

Paragon 28 (NYSE: FNA), ein spezialisiertes Medizintechnikunternehmen, das sich auf Fuß- und Sprunggelenkorthopädie konzentriert, hat seine Teilnahme an der 36. jährlichen Piper Sandler Gesundheitskonferenz bekannt gegeben. Der Vorsitzende und CEO Albert DaCosta sowie CFO Chadi Chahine werden am Dienstag, den 3. Dezember 2024, um 8:30 Uhr Eastern Time an einem Gespräch teilnehmen. Die Präsentation wird über einen Live-Stream sowie eine archivierte Aufnahme auf der Investor-Relations-Website des Unternehmens unter ir.paragon28.com zugänglich sein.

Positive
  • None.
Negative
  • None.

ENGLEWOOD, Colo.--(BUSINESS WIRE)-- Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced that Albert DaCosta, Chairman and CEO, and Chadi Chahine, CFO, will participate in a fireside chat at the 36th Annual Piper Sandler Healthcare Conference on Tuesday, December 3, 2024, at 8:30 a.m. Eastern Time / 6:30 a.m. Mountain Time.

A live webcast, as well as the archived recording, will be available on the investor relations section of the Company’s website at ir.paragon28.com.

About Paragon 28, Inc.

Based in Englewood, Colo., Paragon 28 is a leading medical device company exclusively focused on the foot and ankle orthopedic market and is dedicated to improving patient lives. From the onset, Paragon 28® has provided innovative orthopedic solutions, procedural approaches and instrumentation that cover a wide range of foot and ankle ailments including fracture fixation, forefoot, ankle, progressive collapsing foot deformity (PCFD) or flatfoot, charcot foot and orthobiologics. The company designs products with both the patient and surgeon in mind, with the goal of improving outcomes, reducing ailment recurrence and complication rates, and making the procedures simpler, consistent, and reproducible.

Investor Contact:

Matt Brinckman

Senior Vice President, Strategy and Investor Relations

(720) 912-1332

mbrinckman@paragon28.com

Source: Paragon 28, Inc.

FAQ

When is Paragon 28 (FNA) presenting at the Piper Sandler Healthcare Conference 2024?

Paragon 28 (FNA) will present at the Piper Sandler Healthcare Conference on Tuesday, December 3, 2024, at 8:30 a.m. Eastern Time / 6:30 a.m. Mountain Time.

How can I watch Paragon 28's (FNA) presentation at the Piper Sandler Healthcare Conference?

The presentation can be viewed via live webcast or as an archived recording on Paragon 28's investor relations website at ir.paragon28.com.

Who will represent Paragon 28 (FNA) at the 2024 Piper Sandler Healthcare Conference?

Albert DaCosta, Chairman and CEO, and Chadi Chahine, CFO, will represent Paragon 28 in a fireside chat at the conference.

What type of medical devices does Paragon 28 (FNA) specialize in?

Paragon 28 specializes in medical devices exclusively focused on the foot and ankle orthopedic market.

Paragon 28, Inc.

NYSE:FNA

FNA Rankings

FNA Latest News

FNA Stock Data

874.04M
49.87M
40.56%
60.89%
5.39%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
ENGLEWOOD